Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 6, 2026 · Filed Nov 6, 2026
Not classified as an open-market trade.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
other
Code P in the derivative table; not an open-market share purchase
None found in footnotes
Only flagged when a footnote says so; never inferred
Insider buying
Largest insider buy since 2020Traded Nov 6 · filed the same day
An Annovis Bio director paid $5M out of pocket for Annovis Bio shares. It was the first purchase in 6 months. Shares held went up 149% with this purchase.
Fund moves
The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
